.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent research highlights the necessity of rhythm control in FAMR (atrial functional mitral regurgitation) for patients with heart failure with preserved ejection fraction (HFpEF). While mitral regurgitation often accompanies heart failure, atrial fibrillation (AF) significantly complicates the clinical trajectory. Researchers analyzed 218 patients to see how AF affects regurgitation severity and outcomes. Their findings underscore a vital shift in how clinicians should manage these comorbid conditions.
The study revealed a stark contrast between patients in sinus rhythm and those with AF. Specifically, moderate FAMR occurred in 53.3% of AF patients but only 24.5% of those in sinus rhythm. Furthermore, severe FAMR was nearly twice as common in the AF group. Consequently, atrial fibrillation seems to drive significant valve dysfunction within the HFpEF population by promoting atrial remodeling and annular dilation.
Clinical outcomes significantly worsened for AF patients with severe FAMR. These individuals faced a 4.1-fold higher risk of heart failure hospitalization. Moreover, the risk for the composite endpoint, including cardiovascular death, rose by 2.6 times. In contrast, regurgitation severity did not significantly predict outcomes for patients maintaining a normal sinus rhythm. These data suggest that the combination of AF and FAMR creates a high-risk phenotype that requires targeted intervention.
Clinicians should therefore prioritize rhythm control in FAMR as a core pathogenetic strategy. Restoring sinus rhythm may halt left atrial remodeling and reverse annular dilation. This approach could significantly lower the heavy burden of hospitalizations observed in this patient category. Overall, managing the underlying arrhythmia is just as important as treating the heart failure symptoms themselves to improve long-term survival.
FAMR is a type of heart valve dysfunction where the mitral valve leaks due to atrial enlargement and annular dilation. It typically occurs in patients with atrial fibrillation despite having a preserved left ventricular ejection fraction.
Maintaining sinus rhythm helps reduce the severity of mitral regurgitation. Research shows it specifically lowers the risk of heart failure rehospitalization, which is significantly elevated when AF and severe regurgitation coexist.
Disclaimer: This content is for informational and educational purposes only. It is not intended as medical advice or a substitute for professional healthcare. Always consult a qualified physician for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Study confirms that rhythm control in FAMR is essential for HFpEF patients, as AF-linked severe regurgitation 4.1x increases heart failure hospitalization....
7 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
